← Open Payments lookup

JAMIE ZURCHER: Open Payments

NPI 1093046534 · GRAVOIS MILLS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$810 in 38 payments from 14 companies in 2025. Trend: 2023 $351 · 2024 $679 · 2025 $810

Food & beverage: $810
CompanyPaymentsAmount
Dexcom, Inc.7$159
Neurocrine BioSciences, Inc.5$120
Vanda Pharmaceuticals Inc.3$90
E.R. Squibb & Sons, L.L.C.4$69
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$69
ABBVIE INC.3$54
Otsuka America Pharmaceutical, Inc.3$48
Novo Nordisk Inc2$47
Alkermes, Inc.2$43
AstraZeneca Pharmaceuticals LP1$33

Products named: Dexcom G6 Transmitter, INGREZZA, FANAPT, COBENFY, CAPLYTA, Wegovy, ABILIFY MAINTENA, BREZTRI.

Industry payments across MO — which companies pay providers there.